EN | RU
EN | RU

Help Support

Back

Meaningful relief with flurbiprofen 8.75 mg spray in patients with sore throat due to upper respiratory tract infection

Meaningful relief with flurbiprofen 8.75 mg spray in patients with sore throat due to upper respiratory tract infection Meaningful relief with flurbiprofen 8.75 mg spray in patients with sore throat due to upper respiratory tract infection
Meaningful relief with flurbiprofen 8.75 mg spray in patients with sore throat due to upper respiratory tract infection Meaningful relief with flurbiprofen 8.75 mg spray in patients with sore throat due to upper respiratory tract infection

Assess the effectiveness of 8.75 mg Flurbiprofen sprays for a sore throat.

See All

Key take away

Sore throat is mainly caused by the upper respiratory tract infection (URTI). The number of studies recommended flurbiprofen for the treatment of URTI. But there was variability in the results of these studies. Therefore, in this study, it was showed that 8.75mg of flurbiprofen provides rapid, long-lasting and clinically meaningful relief from sore throat.

Background

Assess the effectiveness of 8.75 mg Flurbiprofen sprays for a sore throat.

Method

The adults with the sore throat due to upper respiratory tract infections administrated with Flurbiprofen or placebo spray and used Sore Throat Relief Rating Scale to assess the pain relief among the patients.

Result

Significant pain relief was seen from 20min to 6h among the patients treated with Flurbiprofen spray than placebo. The Sore Throat Scale exhibited a ≥-2.2 reduction in sore throat severity from 75min to 6h, presenting a significant relief. Considerably more patients from flurbiprofen spray group reported ≥30min of ‘at least moderate’ relief than placebo over 6h. The adverse events noticed during the analysis were mild.

Conclusion

Flurbiprofen spray delivers a rapid, long-lasting and clinically significant relief from a sore throat.

Source:

Pain Manag. 2018 Jan 29.

Article:

Meaningful relief with flurbiprofen 8.75 mg spray in patients with sore throat due to upper respiratory tract infection

Authors:

Ferdinandus de Looze et al.

Comments (0)

You want to delete this comment? Please mention comment Invalid Text Content Text Content cannot me more than 1000 Something Went Wrong Cancel Confirm Confirm Delete Hide Replies View Replies View Replies en
Try: